Pure Global
NCT05676762

Contraceptive Counselling: Impact on Awareness of the Risk of Unwanted Pregnancy and on the Appeal of Contraception

Le Conseil Minimal Autour de la Contraception : Quel Impact Sur la Prise de Conscience du Risque de Grossesse Non désirée et Sur l'Attrait à la Contraception
Centre Hospitalier Universitaire de la Réunion·ClinicalTrials.govNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Contraception
Study type
Observational
Sponsor & location
Primary sponsor
Centre Hospitalier Universitaire de la Réunion
Location
Saint-Philippe, Réunion
Timeline & enrollment
Phase
N/A
Start date
Mar 15, 2022
End date
Jan 15, 2023
Enrollment
117 participants
Primary outcome

Impact of a minimal councelling regarding the contraception awareness of risk of unwanted pregnancy

Summary

The hypothesis of this study is that the generalisation of minimal contraceptive advice in
 general medical consultations among women of childbearing age in Reunion Island who do not
 use contraception but who have sexual relations and do not wish to become pregnant within the
 year could induce an awareness of the risk of unwanted pregnancy and lead to a change in
 behaviour with regard to contraceptive methods.

ICD-10 classifications
Contraceptive managementOral contraceptivesOther contraceptive managementGeneral counselling and advice on contraceptionPersonal history of contraception
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05676762
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05676762 through Pure Global AI's free database. This phase not specified trial is sponsored by Centre Hospitalier Universitaire de la Réunion and is currently Not yet recruiting. The study focuses on Contraception. Target enrollment is 117 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.